OBI Pharma Working Capital to Net Assets Ratio
OBI Pharma working capital to net assets ratio. OBI Pharma (4174) has a Working Capital to Net Assets ratio of 28.0% as of June 2026. Working capital of NT$614.28 Million (current assets of NT$841.46 Million minus current liabilities of NT$227.18 Million) is measured against net assets of NT$2.19 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is OBI Pharma's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of OBI Pharma (2011–2025)
Working capital to net assets ratio of OBI Pharma from 2011 to 2025. This chart shows how OBI Pharma's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 28.0%, reflecting working capital of NT$614.28 Million against net assets of NT$2.19 Billion TWD. See 4174 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
OBI Pharma Working Capital to Net Assets Ratio by Year (2011–2025)
OBI Pharma working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for OBI Pharma from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of OBI Pharma.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.1% | NT$1.23 Billion | NT$2.73 Billion | NT$1.58 Billion | NT$350.56 Million | ▼ -17.7 pp |
| 2024 | 62.8% | NT$3.03 Billion | NT$4.82 Billion | NT$3.44 Billion | NT$412.37 Million | ▲ +2.2 pp |
| 2023 | 60.6% | NT$3.00 Billion | NT$4.95 Billion | NT$3.16 Billion | NT$158.62 Million | ▼ -17.8 pp |
| 2022 | 78.4% | NT$4.81 Billion | NT$6.14 Billion | NT$5.03 Billion | NT$221.14 Million | ▲ +13.2 pp |
| 2021 | 65.3% | NT$2.53 Billion | NT$3.87 Billion | NT$2.85 Billion | NT$327.22 Million | ▼ -10.1 pp |
| 2020 | 75.4% | NT$3.65 Billion | NT$4.84 Billion | NT$3.89 Billion | NT$248.49 Million | ▼ -11.2 pp |
| 2019 | 86.6% | NT$4.51 Billion | NT$5.20 Billion | NT$4.71 Billion | NT$200.00 Million | ▲ +4.1 pp |
| 2018 | 82.5% | NT$3.69 Billion | NT$4.47 Billion | NT$3.79 Billion | NT$103.82 Million | ▼ -9.3 pp |
| 2017 | 91.8% | NT$4.64 Billion | NT$5.06 Billion | NT$4.71 Billion | NT$68.65 Million | ▲ +30.4 pp |
| 2016 | 61.4% | NT$3.78 Billion | NT$6.16 Billion | NT$3.88 Billion | NT$97.46 Million | ▲ +30.3 pp |
| 2015 | 31.1% | NT$2.23 Billion | NT$7.18 Billion | NT$2.36 Billion | NT$127.00 Million | ▼ -30.8 pp |
| 2014 | 61.9% | NT$893.11 Million | NT$1.44 Billion | NT$937.35 Million | NT$44.24 Million | ▼ -3.6 pp |
| 2013 | 65.4% | NT$1.26 Billion | NT$1.93 Billion | NT$1.30 Billion | NT$41.46 Million | ▼ -23.2 pp |
| 2012 | 88.6% | NT$735.41 Million | NT$829.77 Million | NT$779.82 Million | NT$44.40 Million | ▲ +0.4 pp |
| 2011 | 88.2% | NT$448.51 Million | NT$508.44 Million | NT$462.78 Million | NT$14.27 Million | — |